Suchergebnisse - "Boyd, Sarita"

PubPharm (14)

1

Cobicistat-containing antiretroviral regimens are not recommended during pregnancy : viewpoint

enthalten in: AIDS (London, England) | 2019

von Boyd, S. | Sampson, M. | Viswanathan, P. | +3

2

US FDA Perspective on Elbasvir/Grazoprevir Treatment for Patients with Chronic Hepatitis C Virus Genotype 1 or 4 Infection

enthalten in: Clinical drug investigation | 2017

von Boyd, S. | Tracy, L. | Komatsu, T. | +4

3

Regulatory Analysis of Effects of Hepatitis C Virus NS5A Polymorphisms on Efficacy of Elbasvir and Grazoprevir

enthalten in: Gastroenterology | 2017

von Komatsu, T. | Boyd, S. | Sherwat, A. | +4

4

US FDA Perspective on Elbasvir/Grazoprevir Treatment for Patients with Chronic Hepatitis C Virus Genotype 1 or 4 Infection

enthalten in: Clinical drug investigation | 2017

von Boyd, S. | Tracy, L. | Komatsu, T. | +4

5

US FDA Perspective on Elbasvir/Grazoprevir Treatment for Patients with Chronic Hepatitis C Virus Genotype 1 or 4 Infection

enthalten in: Clinical drug investigation | 2017

von Boyd, S. | Tracy, L. | Komatsu, T. | +4

6

Regulatory Analysis of Effects of Hepatitis C Virus NS5A Polymorphisms on Efficacy of Elbasvir and Grazoprevir

enthalten in: Gastroenterology | 2017

von Komatsu, T. | Boyd, S. | Sherwat, A. | +4

7

US FDA Perspective on Elbasvir/Grazoprevir Treatment for Patients with Chronic Hepatitis C Virus Genotype 1 or 4 Infection

enthalten in: Clinical drug investigation | 2017

von Boyd, S. | Tracy, L. | Komatsu, T. | +4

8

Influence of low-dose ritonavir with and without darunavir on the pharmacokinetics and pharmacodynamics of inhaled beclomethasone

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2013

von Boyd, S. | Hadigan, C. | McManus, M. | +7

9

Impaired maraviroc and raltegravir clearance in a human immunodeficiency virus-infected patient with end-stage liver disease and renal impairment : a management dilemma

enthalten in: Pharmacotherapy | 2012

von Pau, A. | Penzak, S. | Boyd, S. | +2

10

Impaired Maraviroc and Raltegravir Clearance in a Human Immunodeficiency Virus–Infected Patient with End‐Stage Liver Disease and Renal Impairment: A Management Dilemma

enthalten in: Pharmacotherapy | 2012

von Pau, A. | Penzak, S. | Boyd, S. | +2